capivasertib | Search results

Showing 1 to 2 of 2 results for capivasertib

Sort by

Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatment ID6370
In development [GID-TA11513] Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development
Capivasertib with paclitaxel for untreated metastatic triple-negative breast cancer [ID6383]
Awaiting development [GID-TA11411] Expected publication date: TBC
Result type
Technology appraisal guidance
Status
Awaiting development